Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal.

Fabián P AlvarezPierre ChevalierMatthias BormsHélène BricoutCatia MarquesAnu SoininenTatu SainioChristine PetitCaroline de Courville

Published in: Journal of medical economics (2023)

In three European countries with different healthcare systems, HD-QIV would contribute to a significant improvement in the prevention of influenza health outcomes while being cost-effective.

Keyphrases

high dose
healthcare
low dose
stem cell transplantation
middle aged
community dwelling
health information